Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
03/2013
03/20/2013CN102977015A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin
03/14/2013US20130065917 Salt of naphthyridine carboxylic acid derivative
03/13/2013CN1938244B Fluoridation method
03/13/2013CN102964303A Sinomenine derivate and preparation method and application thereof
03/13/2013CN102964302A Morphinan compounds
03/13/2013CN101948427B Method for converting diester aconitum alkaloids into talatisamine alkaloids
03/12/2013US8394787 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
03/07/2013WO2013030111A1 Structural mimetics of proline-rich peptides and use thereof
03/07/2013WO2013029260A1 Carbonylpropylsulfonyl anthracene pyridone sulfonic acid compound and preparation method and use thereof
03/06/2013EP2563764A1 Novel spiropiperidine prolylcarboxypeptidase inhibitors
03/06/2013CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/06/2013CN102952074A Method of recycling dextromethorphan from crystallization mother liquor
03/06/2013CN102952073A Method for synthesizing dihydrogen phenanthridine
03/06/2013CN102952072A Incarvillateine analogue, as well as preparation and application thereof in analgesics
03/06/2013CN102614120B Preparation method for sinomenine hydrochloride eye drops
03/06/2013CN101679273B 1-substituted tetrahydroisoquinoline compound
03/05/2013US8389561 Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions
03/05/2013US8389539 Azacyclic derivatives
02/2013
02/28/2013WO2013028999A1 Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders
02/28/2013WO2013026947A1 Light-controlled activation and internalisation of small molecules that can bind to double-stranded dna
02/28/2013US20130053404 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
02/27/2013EP2561873A1 Structural mimetics of proline-rich peptides and use of same
02/27/2013CN102947964A Use of substituted perylenes in organic solar cells
02/27/2013CN102946741A Organic compounds
02/27/2013CN102942482A Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
02/21/2013WO2013025664A1 Indenopyridine derivatives
02/21/2013WO2013024730A1 Organic electroluminescent element, compound for organic electroluminescent element, and light-emitting device, display device, and illumination device using said element
02/21/2013WO2013024026A1 Fluorinated perylene-based semiconducting materials
02/20/2013CN102936221A 桥联环状胺化合物以及有害生物防除剂 Bridged cyclic amine compound and a pest control agent
02/20/2013CN102127014B Azaphenanthrone compound and preparation method thereof
02/19/2013US8378101 Organic semiconductor, photoelectric conversion device, imaging device and novel compounds
02/19/2013US8377935 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
02/19/2013CA2572350C Tetrahydroquinolines
02/14/2013US20130038515 Novel organic compound and organic light-emitting device including the same
02/13/2013EP2556856A1 6-Cyano-substituted Pyrido[2,3-d]pyrimidines as Adenosin Rezeptor Ligands for the Treatment of Cardiovascular Diseases
02/13/2013EP2556831A1 3,4-Dihydro-4-oxo-5-aryl-pyrido[2,3-d]pyrimidine-6-carbonitriles as Adenosin Receptor Ligands for Treatment of Cardiovascular Diseases
02/13/2013EP2556057A1 7,11-methanocycloocta [b]quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
02/13/2013CN102933553A 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
02/13/2013CN102924376A Method for preparing high-purity bulleyaconitine A
02/12/2013US8372863 Tetrahydro-1H-pyrrolo fused pyridones
02/12/2013US8372861 Inhibitors of the unfolded protein response and methods for their use
02/06/2013EP2552890A1 Polycyclic tetracycline compounds
02/06/2013EP2552206A1 Trycyclic compounds and pbk inhibitors containing the same
02/06/2013CN1993327B 3-Carbamoyl-2-pyridone derivative
02/06/2013CN102917590A Trycyclic compounds and pbk inhibitors containing the same
02/06/2013CN102911117A Naphthylamine derivative and purpose thereof
02/06/2013CN102397264B Method for preparing sinomenine hydrochloride sustained-release tablet
02/05/2013US8367827 Process for preparing hydrocodone using a super acid
02/05/2013US8367696 Aza-bridged-ring compound
02/05/2013US8367666 3-carbamoyl-2-pyridone derivatives
02/05/2013US8367654 8-AZA tetracycline compounds
01/2013
01/31/2013WO2013013505A1 9-aminomethyl substituted tetracycline compound
01/31/2013WO2013013504A1 Tigecycline derivative
01/31/2013CA2842838A1 9-aminomethyl substituted tetracycline compounds
01/30/2013EP2550253A2 Carboxamide biosiosteres of opiates
01/30/2013CN102898372A Preparation method of dextromethorphan
01/30/2013CN102898371A Chiral polycyclic piperidine derivative, synthetic method and application
01/30/2013CN102898354A Oxime ether derivatives of spirocyclic tetronic acid, the preparation thereof, and insecticidal, acaricidal, bactericidal and herbicidal usages thereof
01/30/2013CN101379038B Fluorescent whitening agent, composition thereof and methods of preparation and uses thereof
01/29/2013US8362028 Pseudobase benzo[c]phenanthridines with improved efficacy, stability and safety
01/24/2013WO2013010218A1 Inhibition of clathrin
01/24/2013US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications
01/24/2013US20130023498 MicroRNA Modulators and Method for Identifying and Using the Same
01/23/2013EP2547203A1 Ccr5 modulators for treating hiv
01/23/2013CN102887856A Method for synthesizing Blonanserin
01/23/2013CN102397265B Method for preparing sinomenine hydrochloride membrane-controlled enteric controlled-release tablet
01/17/2013WO2012125871A3 Aconitine compounds, compositions, uses, and preparation thereof
01/16/2013EP2546309A1 Anthrapyridone sulphonic acid compounds, preparation and use thereof
01/16/2013CN102875548A Oxime-based method for synthesis of pyridine derivative by [2+2+2] cycloaddition
01/16/2013CN102875467A 1,3-disubstituted-3-diazabicyclo[3,3,1] nonane derivative and preparation method thereof
01/16/2013CN102872915A Iron catalyst system for preparation of pyridine derivatives and its application
01/15/2013US8354534 Selective opioid compounds
01/15/2013US8354423 Insecticidal spironindane derivatives
01/15/2013US8354403 Pyrrolidine derived beta 3 adrenergic receptor agonists
01/10/2013WO2013004290A1 Cyclic amine derivatives as ep4 receptor antagonists
01/10/2013US20130012723 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof
01/10/2013US20130012597 Temperature-, ph- or salt concentration-sensitive separation material and use thereof
01/10/2013US20130011929 Peripheral opioid receptor antagonists and uses thereof
01/10/2013CA2839116A1 Cyclic amine derivatives as ep4 receptor antagonists
01/09/2013CN102863381A Novel method for extracting huperzine A from huperzia serrata
01/08/2013US8350036 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
01/08/2013US8350035 Fluorinated rylenetetracarboxylic acid derivatives and use thereof
01/08/2013US8349825 Spirocyclic compounds
01/03/2013US20130005759 Small molecule modifiers of microrna mir-122
01/03/2013US20130005675 Quinolone compound and pharmaceutical composition
01/03/2013US20130001529 Heterocyclic compound and organic light-emitting device including the same
01/03/2013US20130001527 Heterocyclic compound, organic light-emitting diode including the heterocyclic compound, and flat display device including the organic light-emitting diode
01/03/2013US20130001522 Heterocyclic compound and organic light-emitting device including the same
01/02/2013EP2538780A1 Estrogen receptor ligands and methods of use thereof
01/02/2013CN102850322A Heterocyclic compound, organic light-emitting device, and panel display device
01/02/2013CN102850272A Azido-containing naphthalimide compound and applications thereof in detecting hydrogen sulfide
01/01/2013US8343994 Fluorene compound and pharmaceutical use thereof
12/2012
12/27/2012WO2012175962A1 COMPOUNDS FOR USE IN STABILISING p53 MUTANTS
12/27/2012US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments
12/27/2012US20120329743 Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators
12/27/2012US20120329085 Fluorescent probes for reactive sulfur species
12/26/2012CN102844304A Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
12/26/2012CN102838540A Method for extracting aconitum vilmorimianum kom ketone
12/26/2012CN102838492A Novel compound and organic light-emitting device including the same
12/26/2012CN102070527B Method for extracting high-purity huperzine A and huperzine B from medicinal plant phlegmariurus crutomerianus
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 110